Articles:

Update on endocrine therapy for breast cancer

AU Buzdar and G Hortobagyi
Clin Cancer Res 1998 4: 527 [Abstract] [PDF]  

Telomerase: a potential marker of bladder transitional cell carcinoma in bladder washes

DH Lee, SC Yang, SJ Hong, BH Chung, and IY Kim
Clin Cancer Res 1998 4: 535 [Abstract] [PDF]  

Presence of multiple incontiguous deleted regions at the long arm of chromosome 18 in head and neck cancer

VA Papadimitrakopoulou, Y Oh, A El-Naggar, J Izzo, G Clayman, and L Mao
Clin Cancer Res 1998 4: 539 [Abstract] [PDF]  

Pharmacodynamics of topoisomerase I inhibition: Western blot determination of topoisomerase I and cleavable complex in patients with upper gastrointestinal malignancies treated with topotecan

L Liebes, M Potmesil, T Kim, D Pease, M Buckley, D Fry, J Cho, H Adler, K Dar, A Zeleniuch-Jacquotte, and H Hochster
Clin Cancer Res 1998 4: 545 [Abstract] [PDF]  

The prognostic role of p53, metallothionein, P-glycoprotein, and MIB-1 in muscle-invasive urothelial transitional cell carcinoma

LL Siu, D Banerjee, RJ Khurana, X Pan, R Pflueger, IF Tannock, and MJ Moore
Clin Cancer Res 1998 4: 559 [Abstract] [PDF]  

The overexpression of RHAMM, a hyaluronan-binding protein that regulates ras signaling, correlates with overexpression of mitogen-activated protein kinase and is a significant parameter in breast cancer progression

C Wang, AD Thor, DH Moore, 2nd, Y Zhao, R Kerschmann, R Stern, PH Watson, and EA Turley
Clin Cancer Res 1998 4: 567 [Abstract] [PDF]  

Expression of Bcl-X(L), an antiapoptotic member of the Bcl-2 family, in esophageal squamous cell carcinoma

M Torzewski, M Sarbia, H Heep, P Dutkowski, R Willers, and HE Gabbert
Clin Cancer Res 1998 4: 577 [Abstract] [PDF]  

Minimal recruitment and activation of dendritic cells within renal cell carcinoma

AJ Troy, KL Summers, PJ Davidson, CH Atkinson, and DN Hart
Clin Cancer Res 1998 4: 585 [Abstract] [PDF]  

Phase I and pharmacokinetic study of GI147211, a water-soluble camptothecin analogue, administered for five consecutive days every three weeks

SG Eckhardt, SD Baker, JR Eckardt, TG Burke, DL Warner, JG Kuhn, G Rodriguez, S Fields, A Thurman, L Smith, ML Rothenberg, L White, P Wissel, R Kunka, S DePee, D Littlefield, HA Burris, DD Von Hoff, and EK Rowinsky
Clin Cancer Res 1998 4: 595 [Abstract] [PDF]  

A phase I and pharmacokinetic study of LY231514, the multitargeted antifolate

AC McDonald, PA Vasey, L Adams, J Walling, JR Woodworth, T Abrahams, S McCarthy, NP Bailey, N Siddiqui, MJ Lind, AH Calvert, CJ Twelves, J Cassidy, and SB Kaye
Clin Cancer Res 1998 4: 605 [Abstract] [PDF]  

Phase Ib trial of bryostatin 1 in patients with refractory malignancies

S Grant, J Roberts, E Poplin, MB Tombes, B Kyle, D Welch, M Carr, and HD Bear
Clin Cancer Res 1998 4: 611 [Abstract] [PDF]  

Active immunotherapy with ultraviolet B-irradiated autologous whole melanoma cells plus DETOX in patients with metastatic melanoma

O Eton, DD Kharkevitch, MA Gianan, MI Ross, K Itoh, MW Pride, C Donawho, AC Buzaid, PF Mansfield, JE Lee, SS Legha, C Plager, NE Papadopoulos, AY Bedikian, RS Benjamin, and CM Balch
Clin Cancer Res 1998 4: 619 [Abstract] [PDF]  

Phase I study of the orally administered butyrate prodrug, tributyrin, in patients with solid tumors

BA Conley, MJ Egorin, N Tait, DM Rosen, EA Sausville, G Dover, RJ Fram, and DA Van Echo
Clin Cancer Res 1998 4: 629 [Abstract] [PDF]  

Phase I/II trial of all-trans retinoic acid and tamoxifen in patients with advanced breast cancer

GT Budd, PC Adamson, M Gupta, P Homayoun, SK Sandstrom, RF Murphy, D McLain, L Tuason, D Peereboom, RM Bukowski, and R Ganapathi
Clin Cancer Res 1998 4: 635 [Abstract] [PDF]  

Interferon-gamma and monoclonal antibody 131I-labeled CC49: outcomes in patients with androgen-independent prostate cancer

SF Slovin, HI Scher, CR Divgi, V Reuter, G Sgouros, M Moore, K Weingard, R Pettengall, M Imbriaco, A El-Shirbiny, R Finn, J Bronstein, C Brett, D Milenic, A Dnistrian, L Shapiro, J Schlom, and SM Larson
Clin Cancer Res 1998 4: 643 [Abstract] [PDF]  

Pharmacokinetics of cladribine in plasma and its 5'-monophosphate and 5'-triphosphate in leukemic cells of patients with chronic lymphocytic leukemia

F Albertioni, S Lindemalm, V Reichelova, B Pettersson, S Eriksson, G Juliusson, and J Liliemark
Clin Cancer Res 1998 4: 653 [Abstract] [PDF]  

Significance of circulating hepatocyte growth factor level as a prognostic indicator in primary breast cancer

M Toi, T Taniguchi, T Ueno, M Asano, N Funata, K Sekiguchi, H Iwanari, and T Tominaga
Clin Cancer Res 1998 4: 659 [Abstract] [PDF]  

Epstein-Barr viral DNA in serum of patients with nasopharyngeal carcinoma

A Mutirangura, W Pornthanakasem, A Theamboonlers, V Sriuranpong, P Lertsanguansinchi, S Yenrudi, N Voravud, P Supiyaphun, and Y Poovorawan
Clin Cancer Res 1998 4: 665 [Abstract] [PDF]  

Prognostic value of chorionic gonadotropin beta gene transcripts in human breast carcinoma

I Bieche, V Lazar, C Nogues, T Poynard, Y Giovangrandi, D Bellet, R Lidereau, and M Vidaud
Clin Cancer Res 1998 4: 671 [Abstract] [PDF]  

Proliferative activity and micronucleus frequency after radiation of lung cancer cells as assessed by the cytokinesis-block method and their relationship to clinical outcome

Y Shibamoto, O Ike, H Mizuno, T Fukuse, S Hitomi, and M Takahashi
Clin Cancer Res 1998 4: 677 [Abstract] [PDF]  

Effect of pyrazoloacridine (NSC 366140) on DNA topoisomerases I and II

AA Adjei, M Charron, EK Rowinsky, PA Svingen, J Miller, JM Reid, J Sebolt-Leopold, MM Ames, and SH Kaufmann
Clin Cancer Res 1998 4: 683 [Abstract] [PDF]  

Inhibition of cell growth and telomerase activity of breast cancer cells in vitro by 3'-azido-3'-deoxythymidine

SM Melana, JF Holland, and BG Pogo
Clin Cancer Res 1998 4: 693 [Abstract] [PDF]  

Tamoxifen-resistant fibroblast growth factor-transfected MCF-7 cells are cross-resistant in vivo to the antiestrogen ICI 182,780 and two aromatase inhibitors

SW McLeskey, L Zhang, D El-Ashry, BJ Trock, CA Lopez, S Kharbanda, CA Tobias, LA Lorant, RS Hannum, RB Dickson, and FG Kern
Clin Cancer Res 1998 4: 697 [Abstract] [PDF]  

Efficient generation of autologous peripheral blood-derived cytotoxic T lymphocytes against poorly immunogenic human tumors using recombinant CD80-adenovirus together with interleukin 12 and interleukin 2

S Mogi, T Ebata, Y Setoguchi, M Fujime, Y Heike, T Kohsaka, H Yagita, K Okumura, and M Azuma
Clin Cancer Res 1998 4: 713 [Abstract] [PDF]  

Bispecific antibodies increase T-cell stimulatory capacity in vitro of human autologous virus-modified tumor vaccine

C Haas, G Strauss, G Moldenhauer, RM Iorio, and V Schirrmacher
Clin Cancer Res 1998 4: 721 [Abstract] [PDF]  

Mechanisms for ganciclovir resistance in gastrointestinal tumor cells transduced with a retroviral vector containing the herpes simplex virus thymidine kinase gene

L Yang, R Hwang, Y Chiang, EM Gordon, WF Anderson, and D Parekh
Clin Cancer Res 1998 4: 731 [Abstract] [PDF]  

Studies of the efficacy and pharmacology of irinotecan against human colon tumor xenograft models

WC Zamboni, CF Stewart, PJ Cheshire, LB Richmond, SK Hanna, X Luo, C Poquette, JP McGovren, JA Houghton, and PJ Houghton
Clin Cancer Res 1998 4: 743 [Abstract] [PDF]  

Synergistic effects of 8-chlorocyclic-AMP and retinoic acid on induction of apoptosis in Ewing's sarcoma CHP-100 cells

RK Srivastava, AR Srivastava, and YS Cho-Chung
Clin Cancer Res 1998 4: 755 [Abstract] [PDF]  

Combined antitumor effect of radiation and ibuprofen in human prostate carcinoma cells

ST Palayoor, EA Bump, SK Calderwood, S Bartol, and CN Coleman
Clin Cancer Res 1998 4: 763 [Abstract] [PDF]  

Chemosensitization of glioblastoma cells to bis-dichloroethyl-nitrosourea with tyrphostin AG17

BC Liang and E Ullyatt
Clin Cancer Res 1998 4: 773 [Abstract] [PDF]  

Phenytoin alters the disposition of topotecan and N-desmethyl topotecan in a patient with medulloblastoma

WC Zamboni, AJ Gajjar, RL Heideman, JH Beijnen, H Rosing, PJ Houghton, and CF Stewart
Clin Cancer Res 1998 4: 783 [Abstract] [PDF]  

Overexpression of Lerk-5/Eplg5 messenger RNA: a novel marker for increased tumorigenicity and metastatic potential in human malignant melanomas

T Vogt, W Stolz, J Welsh, B Jung, RS Kerbel, H Kobayashi, M Landthaler, and M McClelland
Clin Cancer Res 1998 4: 791 [Abstract] [PDF]  

Lineage-negative human leukocyte antigen-DR+ cells with the phenotype of undifferentiated dendritic cells in patients with carcinoma of the abdomen and pelvis

B Melichar, C Savary, AP Kudelka, C Verschraegen, JJ Kavanagh, CL Edwards, CD Platsoucas, and RS Freedman
Clin Cancer Res 1998 4: 799 [Abstract] [PDF]  

Homozygous deletion of the PTEN tumor suppressor gene in a subset of prostate adenocarcinomas

SI Wang, R Parsons, and M Ittmann
Clin Cancer Res 1998 4: 811 [Abstract] [PDF]  

To see an article, click its [Full Text] or [PDF] link. To review many abstracts, check the boxes to the left of the titles you want, and click the 'Get All Checked Abstract(s)' button. To see one abstract at a time, click its [Abstract] link.